DACH1 and hepatocellular carcinoma: Based on the previous report that the hypermethylation in the promoter region could give rise to loss or reduction of DACH1 in HCC [19], it is convincible that such epigenetic changes may be at least in part responsible for the aberrant activation of β-catenin downstream targets.